Maria A. Frassanito

Bari, 70124, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management.

Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management.

Journal: Cancers

Published: August 13, 2024

Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma.

Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 26, 2024

RhoB plays a central role in hyperosmolarity-induced cell shrinkage in renal cells.

RhoB plays a central role in hyperosmolarity-induced cell shrinkage in renal cells.

Journal: Journal of cellular physiology

Published: November 28, 2023

Anti-Angiogenic Activity of Drugs in Multiple Myeloma.

Anti-Angiogenic Activity of Drugs in Multiple Myeloma.

Journal: Cancers

Published: February 20, 2023

Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications.

Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications.

Journal: Biomedicines

Published: January 04, 2023

Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance.

Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance.

Journal: Journal of clinical medicine

Published: October 09, 2022

circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer.

circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer.

Journal: Genes, chromosomes & cancer

Published: October 07, 2022

Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives.

Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives.

Journal: International journal of molecular sciences

Published: June 10, 2022

The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value.

The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value.

Journal: Journal of clinical medicine

Published: April 04, 2022

The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic Opportunities.

The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic Opportunities.

Journal: Cancers

Published: February 10, 2022

Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis.

Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis.

Journal: Frontiers in medicine

Published: January 26, 2022

Role of Extracellular Vesicle-Based Cell-to-Cell Communication in Multiple Myeloma Progression.

Role of Extracellular Vesicle-Based Cell-to-Cell Communication in Multiple Myeloma Progression.

Journal: Cells

Published: October 11, 2021

Showing 1-12 of 54

Last Updated: 09/26/2026